Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

• Sascha Venturelli ,

  Contributed equally to this work with: Sascha Venturelli, Alexander Berger

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tuebingen, Germany

  ⨯
• Alexander Berger ,

  Contributed equally to this work with: Sascha Venturelli, Alexander Berger

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tuebingen, Germany

  ⨯
• Alexander Böcker,

  Affiliation Evotec AG, Hamburg, Germany

  ⨯
• Christian Busch,

  Affiliation Section of Dermato-Oncology, Department of Dermatology and Allergology, University of Tuebingen, Tuebingen, Germany

  ⨯
• Timo Weiland,

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tuebingen, Germany

  ⨯
• Seema Noor,

  Affiliation Section of Dermato-Oncology, Department of Dermatology and Allergology, University of Tuebingen, Tuebingen, Germany

  ⨯
• Christian Leischner,

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tuebingen, Germany

  ⨯
• Sabine Schleicher,

  Affiliation University Children's Hospital, Department of Hematology/Oncology, University of Tuebingen, Tuebingen, Germany

  ⨯
• Mascha Mayer,

  Affiliation Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany

  ⨯
• Thomas S. Weiss,

  Affiliation Center for Liver Cell Research, Department of Pediatrics and Adolescent Medicine, University of Regensburg Hospital, Regensburg, Germany

  ⨯
• Stephan C. Bischoff,

  Affiliation Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany

  ⨯
• Ulrich M. Lauer,

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tuebingen, Germany

  ⨯
• Michael Bitzer

  * E-mail: michael.bitzer@uni-tuebingen.de

  Affiliation Department of Internal Medicine I, Medical University Hospital, Tuebingen, Germany

  ⨯